Prevalence of substance use disorders among patients with systemic lupus erythematous and major depressive disorder

Author:

Varghese Kevin J.1,Dellenbaugh Alexandra2,Cao Fei34,Burgess Douglas M.35,Yan Xiaofeng3ORCID

Affiliation:

1. School of Medicine University of Missouri‐Kansas City Kansas City Missouri USA

2. School of Biological and Chemical Sciences University of Missouri‐Kansas City Kansas City Missouri USA

3. Department of Psychiatry University of Missouri‐Kansas City Kansas City 64108 Missouri USA

4. University Health Pain Management Kansas City Missouri USA

5. University Health‐Truman Medical Center Kansas City Missouri USA

Abstract

AbstractBackgroundMajor depressive disorder (MDD) has a higher prevalence among patients with systemic lupus erythematous (SLE). Patients with SLE struggle with stressors such as social stigma and reduced employment. Furthermore, substance use disorders (SUD) are strongly associated with MDD.ObjectivesThis research investigated whether comorbid MDD among patients with SLE is associated with an increased prevalence of SUD diagnoses. Rates of various SUD diagnoses were compared among patients with SLE.MethodsThis was a retrospective comparison study of the medical record. All data were extracted from I2B2, a deidentified dataset from an academic hospital in an urban setting. Upon stratifying patients with SLE into two groups with or without MDD, chi‐squared test comparing SUD was completed. An additional analysis stratified patients with MDD into two groups with or without comorbid SLE and completed the chi‐squared test to compare SUD.ResultsPatients with SLE and comorbid MDD were more likely to have diagnoses of tobacco, alcohol, and opioid disorders, among others. The most common SUD was tobacco (prevalence 59.94%). Furthermore, the diagnosis of SLE among patients with MDD was not associated with increased rates of SUD diagnosis. However, patients diagnosed with comorbid SLE and MDD were more likely to have tobacco use and opioid use disorder diagnosis.ConclusionsThis study demonstrates a consistently higher rate of SUD diagnoses among patients diagnosed with SLE and comorbid MDD versus SLE alone. Rates of both tobacco and opioid use disorder were higher among patients with MDD and comorbid SLE when compared to MDD alone. Our study is limited by its retrospective analysis and does not include an analysis of the treatment of comorbid depression on SUD. For clinicians who take care of patients with SLE, when they have comorbid MDD, SUD should be screened.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3